laitimes

Bahrain approves Sinopharm's COVID-19 vaccine for children aged 3 to 11 years

According to The Alberia TV Station quoted Reuters on the 26th, Bahrain's National Information Office said on Tuesday that it has approved the Sinopharm new crown vaccine for children aged 3 to 11 years from October 27. The Pfizer COVID-19 vaccine will soon be approved for use in children aged 5 to 11 years.